Cosentyx is a prescription medicine that is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis [1]. It works by blocking a specific protein in the body that causes inflammation. However, there are certain health conditions in which Cosentyx is not recommended.

According to the manufacturer's website, Cosentyx is not recommended for people who have a history of hypersensitivity to secukinumab or any of the other ingredients in Cosentyx [2]. Additionally, it is advised that individuals who have an active infection should not take Cosentyx until the infection is resolved [2].

The Centers for Disease Control and Prevention (CDC) also recommends that immunocompromised individuals, including those taking immunosuppressive medications, should avoid live vaccines and talk to their healthcare provider before receiving any vaccines [3]. This is because immunocompromised individuals may have a reduced response to vaccines and may be at a higher risk of developing infections.

In conclusion, Cosentyx is not recommended for individuals who have a history of hypersensitivity to secukinumab or any of the other ingredients in Cosentyx, as well as those who have an active infection. Immunocompromised individuals should also consult with their healthcare provider before taking Cosentyx or receiving any vaccines [1][2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/covid19
[3] https://wwwnc.cdc.gov/travel/yellowbook/2024/additional-considerations/immunocompromised-travelers